Interest of Simulation Training on the Announcement of Early Pregnancy Loss on the Psychological Impact of the Patients

NCT ID: NCT06647849

Last Updated: 2025-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

1000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-11-11

Study Completion Date

2027-06-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Early pregnancy loss (or spontaneous miscarriage) is the loss of a pregnancy before 14 weeks of amenorrhea. Its incidence is estimated at between 10 and 15%, and increases with maternal age.

Early pregnancy loss can have major psychological consequences for the woman, her partner and the couple in the aftermath, as well as on the experience and progress of a future pregnancy.

In France, the vast majority of miscarriages are diagnosed in gynecological emergencies by interns still in training. Interns, sometimes at the beginning of their training, may find it difficult to announce a miscarriage, and may do so in a way that is clumsy or not adapted to the woman's emotions, which can lead to a bad experience for her. This bad experience could lead to psychological distress, post-traumatic stress and/or impair future fertility.

The initiators of this project have already carried out a before-and-after, single-center study, showing a significant improvement in the specific Perinatal Grief Scale score following specific training for interns in first-trimester pregnancy loss.

To date, no multicenter randomized study has been conducted to assess the impact of first-trimester pregnancy loss on women's psychological experience.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Early Pregnancy Loss Spontaneous Miscarriage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants
The study will be single-blind. The patient will not know the intern's level of training (trained or untrained).

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm "with training"

Arm "with training": centers whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phases.

Group Type EXPERIMENTAL

centers whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phases

Intervention Type PROCEDURE

The simulation training sessions for the announcement consultation are set up directly in the centers participating in the "with training" arm of the study, after the first phase of patient inclusion. These sessions will take place "in situ" in the center's maternity ward, and will be run by a single team trained in simulation and announcement.

This team of trainers is identical for all centers randomized in the "with training" arm, and is made up of two trainers: an obstetrician-gynecologist and a psychologist.

"Untrained" arm

"Untrained" arm: centers with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency department.

Group Type OTHER

centers with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency department

Intervention Type OTHER

In the participating centers included in the "no training" arm, interns will have no specific training in announcement. Patients will receive information concerning the diagnosis of a terminated pregnancy or miscarriage from interns not trained in simulation.

During the course of the study, training in the announcement of a miscarriage will be offered to interns from centers in the "no training" group.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

centers whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phases

The simulation training sessions for the announcement consultation are set up directly in the centers participating in the "with training" arm of the study, after the first phase of patient inclusion. These sessions will take place "in situ" in the center's maternity ward, and will be run by a single team trained in simulation and announcement.

This team of trainers is identical for all centers randomized in the "with training" arm, and is made up of two trainers: an obstetrician-gynecologist and a psychologist.

Intervention Type PROCEDURE

centers with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency department

In the participating centers included in the "no training" arm, interns will have no specific training in announcement. Patients will receive information concerning the diagnosis of a terminated pregnancy or miscarriage from interns not trained in simulation.

During the course of the study, training in the announcement of a miscarriage will be offered to interns from centers in the "no training" group.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patient
* Patient presenting to gynaecological emergency department
* Patient with a diagnosis of terminated pregnancy or spontaneous expulsion of a pregnancy \< 14 weeks' amenorrhea
* Patient whose spontaneous miscarriage was announced by an intern
* Patient affiliated to or benefiting from a social security scheme
* Patient having signed an informed consent form

Exclusion Criteria

* Unwanted pregnancy
* Spontaneous hemorrhagic miscarriage requiring surgical management
* Ectopic pregnancy
* Miscarriage resulting from assisted reproduction treatment
* Patient with history of miscarriage ≥ 3
* Poor understanding of the French language
* Person deprived of liberty by judicial or administrative decision
* Person under forced psychiatric care
* Person subject to a legal protection measure
* Person unable to give consent
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Direction Générale de l'Offre de Soins

OTHER_GOV

Sponsor Role collaborator

University Hospital, Angers

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guillaume Legendre, MD, PhD

Role: STUDY_DIRECTOR

University Hospital of Angers

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital of Amiens

Amiens, , France

Site Status RECRUITING

University Hospital of Angers

Angers, , France

Site Status RECRUITING

University Hospital of Bordeaux

Bordeaux, , France

Site Status NOT_YET_RECRUITING

University Hospital of Brest

Brest, , France

Site Status NOT_YET_RECRUITING

Femme Mere Enfant Hospital

Bron, , France

Site Status NOT_YET_RECRUITING

University Hospital of Caen

Caen, , France

Site Status RECRUITING

CH Chalon-sur-Saône

Chalon-sur-Saône, , France

Site Status RECRUITING

CH Cholet

Cholet, , France

Site Status RECRUITING

University Hospital of Clermont-Ferrand

Clermont-Ferrand, , France

Site Status RECRUITING

University Hospital of Dijon

Dijon, , France

Site Status RECRUITING

CHU Grenoble

Grenoble, , France

Site Status RECRUITING

Vendée Departmental Hospital center

La Roche-sur-Yon, , France

Site Status RECRUITING

Le Mans Hospital

Le Mans, , France

Site Status RECRUITING

Jeanne de Flandre Hospital

Lille, , France

Site Status RECRUITING

University Hospital of Limoges

Limoges, , France

Site Status RECRUITING

Hopital Nord (Marseille Public University Hospital System)

Marseille, , France

Site Status RECRUITING

La Conception Hospital (Marseille Public University Hospital System)

Marseille, , France

Site Status RECRUITING

University Hospital of Montpellier

Montpellier, , France

Site Status RECRUITING

University Hospital of Nancy

Nancy, , France

Site Status RECRUITING

University Hospital of Nantes

Nantes, , France

Site Status RECRUITING

CHU Nice

Nice, , France

Site Status RECRUITING

University Hospital of Nimes

Nîmes, , France

Site Status RECRUITING

CHU Orléans

Orléans, , France

Site Status RECRUITING

Poissy intercommunal hospital center

Poissy, , France

Site Status RECRUITING

University Hsopital of Reims

Reims, , France

Site Status RECRUITING

University Hospital of Rennes

Rennes, , France

Site Status RECRUITING

University Hospital of Rouen

Rouen, , France

Site Status RECRUITING

University Hospital of Saint Etienne

Saint-Etienne, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Guillaume Lengendre, MD, PhD

Role: CONTACT

+33 02 41 35 36 37

DRI UH Angers

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Foulon

Role: primary

+33 03 22 08 74 60

Legendre

Role: primary

+33 0241354459

Loic Sentilhes

Role: primary

Karine MORCEL

Role: primary

Charles-André PHILIP

Role: primary

Fauvet

Role: primary

+33 02 31 27 25 25

Francois Gallon

Role: primary

0385910064 ext. +33-

Mariette BRUAND

Role: primary

Chauvet

Role: primary

+33 04 73 75 50 44

Simon

Role: primary

+33 03 80 29 36 64

Thierry MICHY

Role: primary

Ducarme

Role: primary

+33 02 51 44 65 70

Dubois

Role: primary

+33 02 43 43 43 50

Delporte

Role: primary

+33 03 20 44 66 41

Gauthier

Role: primary

+33 05 55 05 61 64

CARCOPINO-TUSOLI

Role: primary

+33 04 91 96 46 58

Agostini

Role: primary

+33 04 91 38 37 02

Compan

Role: primary

+33 04 67 33 64 52

Dap

Role: primary

+33 03 83 34 43 13

Dochez

Role: primary

+33 02 40 08 31 82

Jérôme DELOTTE

Role: primary

Letouzey

Role: primary

+33 04 66 68 43 15

Hélène GBAGUIDI

Role: primary

Neuranter

Role: primary

+33 01 39 27 45 76

Raimond

Role: primary

+33 03 26 78 76 49

Le Lous

Role: primary

+33 02 23 06 74 59

Crochet

Role: primary

+33 02 32 88 82 44

Barjat

Role: primary

+33 04 77 82 86 09

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A01244-43

Identifier Type: OTHER

Identifier Source: secondary_id

49RC21_0257

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.